VRTX VERTEX PHARMACEUTICALS INC

Ownership history in BRIDGER MANAGEMENT, LLC  ·  15 quarters on record

This page tracks every 13F SEC filing in which BRIDGER MANAGEMENT, LLC reported a position in VERTEX PHARMACEUTICALS INC (VRTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
9.9% (2024 Q2)
Avg. % of fund
5.87%
First filed
2021 Q4
Last filed
2025 Q3
Quarters held
15
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 18,778 0% 3.96% $7.4M $391.64
2025 Q2 REDUCED 18,778 -22,272 -54.3% 4.93% $8.4M $445.20
2025 Q1 UNCHANGED 41,050 0% 9.89% $19.9M $484.82
2024 Q4 UNCHANGED 41,050 0% 8.88% $16.5M $402.70
2024 Q3 UNCHANGED 41,050 0% 9.55% $19.1M $465.08
2024 Q2 UNCHANGED 41,050 0% 9.90% $19.2M $468.72
2024 Q1 REDUCED 41,050 -6,950 -14.5% 7.74% $17.2M $418.01
2023 Q4 ADDED 48,000 +5,600 +13.2% 7.52% $19.5M $406.89
2023 Q3 UNCHANGED 42,400 0% 5.42% $14.7M $347.74
2023 Q2 ADDED 42,400 +25,932 +157.5% 4.97% $14.9M $351.91
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    VRTX price (monthly, adj. close)
← Back to BRIDGER MANAGEMENT, LLC Holdings